Year |
Citation |
Score |
2022 |
Bhatia S, Nguyen D, Darragh LB, Van Court B, Sharma J, Knitz MW, Piper M, Bukkapatnam S, Gadwa J, Bickett TE, Bhuvane S, Corbo S, Wu B, Lee Y, Fujita M, ... ... Rodriguez O, et al. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment. Nature Communications. 13: 3535. PMID 35725568 DOI: 10.1038/s41467-022-31124-7 |
0.318 |
|
2020 |
Gris-Oliver A, Palafox M, Monserrat L, Brasó-Maristany F, Òdena A, Sánchez-Guixé M, Ibrahim YH, Villacampa G, Grueso J, Parés M, Guzman M, Rodriguez O, Bruna A, Hirst CS, Barnicle A, et al. Genetic alterations in the PI3K/AKT pathway and baseline AKT activity define AKT inhibitor sensitivity in breast cancer patient-derived xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220884 DOI: 10.1158/1078-0432.Ccr-19-3324 |
0.349 |
|
2019 |
Ihemelandu C, Naeem A, Parasido E, Berry D, Chaldekas K, Harris BT, Rodriguez O, Albanese C. Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer. Colorectal Cancer. 8: CRC11. PMID 32038737 DOI: 10.2217/Crc-2019-0009 |
0.329 |
|
2019 |
Parasido E, Avetian G, Naeem A, Graham G, Pishvaian M, Glasgow E, Mudambi S, Lee Y, Ihemelandu C, Choudhry M, Peran I, Banerjee PP, Avantaggiati ML, Bryant K, Baldelli E, ... ... Rodriguez O, et al. The sustained induction of c-Myc drives nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells. Molecular Cancer Research : McR. PMID 31164413 DOI: 10.1158/1541-7786.Mcr-19-0191 |
0.328 |
|
2018 |
Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, Rodríguez O, Grueso J, Bonache S, Moles-Fernández A, Villacampa G, et al. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Embo Molecular Medicine. PMID 30377213 DOI: 10.15252/Emmm.201809172 |
0.388 |
|
2018 |
Speidell AP, Demby T, Lee Y, Rodriguez O, Albanese C, Mandelblatt J, Rebeck GW. Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotoxicity Research. PMID 30284204 DOI: 10.1007/S12640-018-9954-7 |
0.326 |
|
2018 |
Tricoli L, Naeem A, Parasido E, Mikhaiel JP, Choudhry MU, Berry DL, Abdelgawad IA, Lee RJ, Feldman AS, Ihemelandu C, Avantaggiati M, Kumar D, Byers S, Gallagher R, Wulfkuhle J, ... ... Rodriguez O, et al. Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells. Oncotarget. 9: 2193-2207. PMID 29416764 DOI: 10.18632/Oncotarget.23363 |
0.348 |
|
2018 |
Galli S, Hong S, Tilan JU, Adnani M, Zhu S, Fallah Y, Lee Y, Rodriguez O, Albanese C, Izycka-Swieszewska E, Kitlinska J. Abstract B13: Perineural invasion in Ewing sarcoma—a novel mechanism and new therapeutic opportunities Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B13 |
0.429 |
|
2018 |
Palafox M, Herrera-Abreu MT, Bellet M, Oliveira M, Bruna A, Rodriguez O, Guzmán M, Grueso J, Vilaplana C, Arribas J, Tomaso Ed, Su F, Caldas C, Turner NC, Dienstmann R, et al. Abstract 3596: Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX) Cancer Research. 78: 3596-3596. DOI: 10.1158/1538-7445.Am2018-3596 |
0.411 |
|
2017 |
Tricoli LJ, Berry D, Parasido E, Naeem A, Rodriguez O, Abdelgawad I, Lee R, Feldman A, Albanese C. Abstract 4829: Development of rapid 3-dimensional culture conditions that support thein vitrodifferentiation of conditionally reprogrammed primary prostate cells for the study of prostate cancer Cancer Research. 77: 4829-4829. DOI: 10.1158/1538-7445.Am2017-4829 |
0.318 |
|
2017 |
Naeem A, Choudhry MU, Avantaggiati ML, Rodriguez OC, Albanese C. Abstract 3178: The p53 tumor suppressor protein paradoxically drives chemo-resistance in human medulloblastoma cells through suppressing the mTOR AKT pathway Cancer Research. 77: 3178-3178. DOI: 10.1158/1538-7445.Am2017-3178 |
0.415 |
|
2017 |
Hong SH, Wietlisbach L, Galli S, Mahajan A, Zhu S, Tilan J, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 1940: Prenatal stress increases malignancy of neuroblastoma tumors in TH-MYCN animal model Cancer Research. 77: 1940-1940. DOI: 10.1158/1538-7445.Am2017-1940 |
0.328 |
|
2017 |
Gris-Oliver A, Oliveira M, Guzman M, Rodríguez O, Grueso J, Scaltriti M, Howat WJ, Barrett JC, Cortés J, Baselga J, Schiavon G, Davies BR, Saura C, Serra V. Abstract 150: Identification of determinants of sensitivity to AKT inhibition using breast cancer (BC) patient-derived tumor xenografts (PDX) Cancer Research. 77: 150-150. DOI: 10.1158/1538-7445.Am2017-150 |
0.408 |
|
2016 |
Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB. In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. Journal of Visualized Experiments : Jove. PMID 28060251 DOI: 10.3791/54532 |
0.378 |
|
2016 |
Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. The American Journal of Pathology. PMID 27743558 DOI: 10.1016/J.Ajpath.2016.07.019 |
0.406 |
|
2016 |
Herrera-Abreu MT, Palafox M, Asghar U, Rivas MA, Cutts RJ, Garcia-Murillas I, Pearson A, Guzman M, Rodriguez O, Grueso J, Bellet M, Cortés J, Elliott R, Pancholi S, Baselga J, et al. Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer. Cancer Research. PMID 27020857 DOI: 10.1158/0008-5472.Can-15-0728 |
0.407 |
|
2016 |
Serra V, Palafox M, Herrera M, Rivas MA, Guzmán M, Rodriguez O, Grueso J, Bellet M, Oliveira M, Saura C, Tomaso Ed, Camponigro G, Turner NC, Cortés J, Baselga J. Abstract 2825: Identification of CDK4/6-response biomarkers using estrogen receptor-positive breast cancer patient-derived xenografts (PDX) Cancer Research. 76: 2825-2825. DOI: 10.1158/1538-7445.Am2016-2825 |
0.403 |
|
2016 |
Tilan JU, Hong S, Galli S, Acree R, Connors K, Horton M, Mahajan A, Wietlisbach L, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 2478: Tumor hypoxia promotes Ewing sarcoma metastases in a mouse xenograft model Cancer Research. 76: 2478-2478. DOI: 10.1158/1538-7445.Am2016-2478 |
0.409 |
|
2016 |
Naeem A, Yenugonda V, Rodriguez O, Avantaggiati M, Rood B, Karam S, Albanese C. Mechanisms of p53-mediated chemosensitivity of VMY on medulloblastoma cells European Journal of Cancer. 61: S90. DOI: 10.1016/S0959-8049(16)61315-1 |
0.322 |
|
2015 |
Bhatia S, Hirsch K, Baig NA, Rodriguez O, Timofeeva O, Kavanagh K, Lee YC, Wang XJ, Albanese C, Karam SD. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model. Journal of Hematology & Oncology. 8: 105. PMID 26345456 DOI: 10.1186/S13045-015-0202-9 |
0.371 |
|
2015 |
García-García C, Rivas MA, Ibrahim YH, Calvo MT, Gris-Oliver A, Rodríguez O, Grueso J, Antón P, Guzmán M, Aura C, Nuciforo P, Jessen K, Argilés G, Dienstmann R, Bertotti A, et al. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26272063 DOI: 10.1158/1078-0432.Ccr-14-3091 |
0.398 |
|
2015 |
Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B, Jung M, Wang XJ, Kool M, Rodriguez O, Albanese C, et al. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget. 6: 8929-46. PMID 25879388 DOI: 10.18632/Oncotarget.3369 |
0.421 |
|
2015 |
Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases. Oncotarget. 6: 7151-65. PMID 25714031 DOI: 10.18632/Oncotarget.3345 |
0.313 |
|
2015 |
Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20. PMID 25065592 DOI: 10.1038/Onc.2014.231 |
0.34 |
|
2015 |
Hong S, Christian D, Trinh E, Galli S, Horton M, Lee Y, Albanese C, Rodriguez O, Tilan JU, Kitlinska J. Abstract 3291: Prenatal stress increases neuroblastoma tumorigenesis in TH-MYCN mice model Cancer Research. 75: 3291-3291. DOI: 10.1158/1538-7445.Am2015-3291 |
0.322 |
|
2014 |
Tian Y, Wang SS, Zhang Z, Rodriguez OC, Petricoin E, Shih IM, Chan D, Avantaggiati M, Yu G, Ye S, Clarke R, Wang C, Zhang B, Wang Y, Albanese C. Integration of network biology and imaging to study cancer phenotypes and responses. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 11: 1009-1019. PMID 25750594 DOI: 10.1109/Tcbb.2014.2338304 |
0.316 |
|
2014 |
Ringer L, Sirajuddin P, Tricoli L, Waye S, Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A, Abdelgawad I, Liu X, Feldman AS, Lee RJ, Wu CL, Yenugonda V, ... ... Rodriguez O, et al. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget. 5: 10678-91. PMID 25296977 DOI: 10.18632/Oncotarget.2528 |
0.444 |
|
2014 |
Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI. Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells. Oncotarget. 5: 1683-98. PMID 24742967 DOI: 10.18632/Oncotarget.1849 |
0.455 |
|
2014 |
Kolukula VK, Sahu G, Wellstein A, Rodriguez OC, Preet A, Iacobazzi V, D'Orazi G, Albanese C, Palmieri F, Avantaggiati ML. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget. 5: 1212-25. PMID 24681808 DOI: 10.18632/Oncotarget.1831 |
0.41 |
|
2014 |
Baig NA, Rodriguez O, Pasquale E, Dritschilo A, Donoghue M, Timofeeva O, Albanese C, Karam SD. Role of the EphA4 and EphA7 genes in mediating the growth and aggressiveness of medulloblastoma tumors in the Smo/Smo medulloblastoma mouse model. Journal of Clinical Oncology. 32: e22137-e22137. DOI: 10.1200/Jco.2014.32.15_Suppl.E22137 |
0.326 |
|
2014 |
Hong S, Galli S, Tilan J, Christian D, Horton M, Rodriguez O, Albanese C, Kitlinska J. Abstract A52: In vivo model of Ewings sarcoma metastases Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A52 |
0.373 |
|
2014 |
Rivas MA, Ibrahim YH, Rodríguez O, Antón P, Cozar P, Gómez-Pardo P, Aura C, Haines BB, Sathyanarayanan S, Zhang T, Serra V, Baselga J. Abstract 924: Predictive biomarker identification for combined anti-mTOR and anti-IGF-1R treatment in luminal B breast cancer Cancer Research. 74: 924-924. DOI: 10.1158/1538-7445.Am2014-924 |
0.329 |
|
2014 |
Baig NA, Timofeeva O, Dritschilo A, Pasquale E, Kool M, Rood B, Rodriguez O, Albanese C, Karam S. Abstract 3458: Role of the EphB1 gene in mediating migration, proliferation, and radiosensitization of medulloblastoma cells Cancer Research. 74: 3458-3458. DOI: 10.1158/1538-7445.Am2014-3458 |
0.453 |
|
2014 |
Baig N, Timofeeva O, Zhao X, Dritschilo A, Pasquale E, Henkemeyer M, Kool M, Rood B, Jung M, Rodriguez O, Albanese C, Karam S. EphB1 Inhibits Migration and Proliferation of Medulloblastoma Tumor Cells and Sensitizes Them to Ionizing Radiation by Mediating a G1 Arrest International Journal of Radiation Oncology*Biology*Physics. 90: S36. DOI: 10.1016/J.Ijrobp.2014.05.150 |
0.347 |
|
2013 |
Albanese C, Rodriguez OC, VanMeter J, Fricke ST, Rood BR, Lee Y, Wang SS, Madhavan S, Gusev Y, Petricoin EF, Wang Y. Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges. The American Journal of Pathology. 182: 312-8. PMID 23219428 DOI: 10.1016/J.Ajpath.2012.09.024 |
0.332 |
|
2013 |
Serra V, Eichhorn PJ, García-García C, Ibrahim Y, Prudkin L, Rodríguez O, Marlow S, Prat A, Hahn WC, Baselga J. Abstract 4452: p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer. Cancer Research. 73: 4452-4452. DOI: 10.1158/1538-7445.Am2013-4452 |
0.386 |
|
2012 |
Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, Reynoso K, Bargonetti J, Wellstein A, Albanese C, Avantaggiati ML. Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle (Georgetown, Tex.). 11: 4436-46. PMID 23151455 DOI: 10.4161/Cc.22778 |
0.34 |
|
2012 |
Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E, et al. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle (Georgetown, Tex.). 11: 3801-9. PMID 22983062 DOI: 10.4161/Cc.21988 |
0.36 |
|
2012 |
Tilan JU, Izycka-Swieszewska E, Earnest JP, Galli S, Shabbir A, Lu C, Czarnecka M, Rodriguez O, Albanese C, Kitlinska J. Abstract LB-186: Differential effects of stress on tumor initiation and progression - role of neuropeptide Y Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-186 |
0.358 |
|
2012 |
Sirajuddin P, Das S, Ringer L, Salinas P, Rodriguez O, Moasser B, Yenugonda VM, Albanese C, Brown M. Abstract 4774: LC-MS/MS detection of the dansyl-modified biologically active CDK inhibitor VMY-1-103 using an in vivo model system Cancer Research. 72: 4774-4774. DOI: 10.1158/1538-7445.Am2012-4774 |
0.321 |
|
2012 |
Ringer L, Sirajuddin P, Yenugonda VM, Brown M, Rodriguez O, Albanese C. Abstract 3052: Role of p53 in cdk inhibitor VMY-1-103-induced apoptosis in prostate cancer Cancer Research. 72: 3052-3052. DOI: 10.1158/1538-7445.Am2012-3052 |
0.428 |
|
2011 |
Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biology & Therapy. 12: 818-26. PMID 21885916 DOI: 10.4161/Cbt.12.9.17682 |
0.427 |
|
2011 |
Kang HJ, Hong YB, Kim HJ, Rodriguez OC, Nath RG, Tilli EM, Albanese C, Chung FL, Kwon SH, Bae I. Detoxification: a novel function of BRCA1 in tumor suppression? Toxicological Sciences : An Official Journal of the Society of Toxicology. 122: 26-37. PMID 21507987 DOI: 10.1093/Toxsci/Kfr089 |
0.379 |
|
2011 |
Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. The Journal of Clinical Investigation. 121: 148-60. PMID 21183792 DOI: 10.1172/Jci42874 |
0.447 |
|
2010 |
Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. Ppar Research. 2010: 571783. PMID 21318167 DOI: 10.1155/2010/571783 |
0.375 |
|
2010 |
Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Cancer Biology & Therapy. 10: 320-5. PMID 20574155 DOI: 10.4161/Cbt.10.4.12208 |
0.437 |
|
2010 |
Vissapragada S, Ghosh A, Ringer L, Salinas P, Brophy A, Peaceman D, Kallakury B, Banerjee PP, Fricke ST, Helfrich W, Lee YC, Pestell R, Scherer P, Tanowitz HB, Avantaggiati ML, ... ... Rodriguez OC, et al. Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (Georgetown, Tex.). 9: 1824-9. PMID 20404514 DOI: 10.4161/Cc.9.9.11542 |
0.312 |
|
2010 |
Sahu G, Rodriguez OC, Kolukula V, Catania J, Preet A, Arshed A, Albanese C, Avantaggiati ML. Abstract 66: Corruption of the activity of the mitochondria citrate transporter, CIC, by mutant forms of p53 Cancer Research. 70: 66-66. DOI: 10.1158/1538-7445.Am10-66 |
0.407 |
|
2010 |
Rodriguez OC, Kokula V, Catania J, Preet A, Arshed A, Pishvaian M, Albanese C, Avantaggiati ML. Abstract 4833: Glucose restriction induces degradation of p53 mutants via a selective autophagy-mediated pathway Cancer Research. 70: 4833-4833. DOI: 10.1158/1538-7445.Am10-4833 |
0.366 |
|
2010 |
Elizalde VS, Russillo M, Scaltriti M, Rodriguez O, Guzman M, Cosimo SD, Baselga J. Abstract 4477: Dual-targeting of AMPK and PI3K/mTOR in a panel of breast cancer cell lines Cancer Research. 70: 4477-4477. DOI: 10.1158/1538-7445.Am10-4477 |
0.415 |
|
2010 |
Beauchamp EM, Rodriguez O, Albanese C, Toretsky JA, Üren A. Abstract 3409: Arsenic trioxide inhibits Ewing sarcoma growth by blocking Hedgehog/GLI pathway Cancer Research. 70: 3409-3409. DOI: 10.1158/1538-7445.Am10-3409 |
0.425 |
|
2009 |
Rodriguez OC, Lai EW, Vissapragada S, Cromelin C, Avetian M, Salinas P, Ramos H, Kallakury B, Casimiro M, Lisanti MP, Tanowitz HB, Pacak K, Glazer RI, Avantaggiati M, Albanese C. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. The American Journal of Pathology. 174: 2051-60. PMID 19443706 DOI: 10.2353/Ajpath.2009.080859 |
0.418 |
|
2009 |
Elizalde VS, Eichhorn PJ, Scaltriti M, Prudkin L, Rodriguez O, Guzman M, Baselga J. Abstract B144: NVP‐BEZ235, a dual inhibitor of PI3K and mTOR, induces MAPK phosphorylation in HER2‐positive cells Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B144 |
0.369 |
|
2007 |
Lai EW, Rodriguez OC, Aventian M, Cromelin C, Fricke ST, Martiniova L, Lubensky IA, Lisanti MP, Picard KL, Powers JF, Tischler AS, Pacak K, Albanese C. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice. Cell Cycle (Georgetown, Tex.). 6: 1946-50. PMID 17671425 DOI: 10.4161/Cc.6.15.4521 |
0.393 |
|
2007 |
Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, et al. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Research. 67: 4364-72. PMID 17483350 DOI: 10.1158/0008-5472.Can-06-1898 |
0.42 |
|
2006 |
Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. The Prostate. 66: 708-17. PMID 16425198 DOI: 10.1002/Pros.20392 |
0.345 |
|
2006 |
Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle (Georgetown, Tex.). 5: 113-9. PMID 16340310 DOI: 10.4161/Cc.5.1.2295 |
0.395 |
|
2005 |
Albanese C, Rodriguez O, Johnson MD, Fricke S. Models of prostate cancer Drug Discovery Today: Disease Models. 2: 7-13. DOI: 10.1016/J.Ddmod.2005.05.002 |
0.329 |
|
2003 |
Tirado OM, Martinez ED, Rodriguez OC, Danielsen M, Selva DM, Reventós J, Munell F, Suárez-Quian CA. Methoxyacetic acid disregulation of androgen receptor and androgen-binding protein expression in adult rat testis. Biology of Reproduction. 68: 1437-46. PMID 12606434 DOI: 10.1095/Biolreprod.102.004937 |
0.668 |
|
1999 |
List HJ, Smith CL, Rodriguez O, Danielsen M, Riegel AT. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: An explanation for trichostatin a effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter Experimental Cell Research. 252: 471-478. PMID 10527637 DOI: 10.1006/Excr.1999.4638 |
0.583 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Scaltriti M, Serra V, Normant E, Guzman M, Rodriguez O, Lim AR, Slocum KL, West KA, Rodriguez V, Prudkin L, Jimenez J, Aura C, Baselga J. Antitumor activity of the Hsp90 inhibitor IPI-504 in HER2-positive trastuzumab-resistant breast cancer. Molecular Cancer Therapeutics. 10: 817-24. PMID 21383049 DOI: 10.1158/1535-7163.MCT-10-0966 |
0.299 |
|
2013 |
Heier CR, Damsker JM, Yu Q, Dillingham BC, Huynh T, Van der Meulen JH, Sali A, Miller BK, Phadke A, Scheffer L, Quinn J, Tatem K, Jordan S, Dadgar S, Rodriguez OC, et al. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. Embo Molecular Medicine. 5: 1569-85. PMID 24014378 DOI: 10.1002/Emmm.201302621 |
0.293 |
|
2015 |
Waye S, Naeem A, Choudhry MU, Parasido E, Tricoli L, Sivakumar A, Mikhaiel JP, Yenugonda V, Rodriguez OC, Karam SD, Rood BR, Avantaggiati ML, Albanese C. The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells. Aging. 7: 854-68. PMID 26540407 |
0.287 |
|
2020 |
Naeem A, Dakshanamurthy S, Walthieu H, Parasido E, Avantaggiati M, Tricoli L, Kumar D, Lee RJ, Feldman A, Noon MS, Byers S, Rodriguez O, Albanese C. Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells. The Prostate. PMID 32761925 DOI: 10.1002/Pros.24050 |
0.287 |
|
2012 |
Ibrahim YH, García-García C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzmán M, Grueso J, Rodríguez O, Calvo MT, Aura C, Díez O, Rubio IT, et al. PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discovery. 2: 1036-47. PMID 22915752 DOI: 10.1158/2159-8290.Cd-11-0348 |
0.283 |
|
2020 |
Demby TC, Rodriguez O, McCarthy CW, Lee YC, Albanese C, Mandelblatt J, Rebeck GW. A Mouse Model of Chemotherapy-Related Cognitive Impairments Integrating the Risk Factors of Aging and APOE4 Genotype. Behavioural Brain Research. 112534. PMID 32027870 DOI: 10.1016/J.Bbr.2020.112534 |
0.283 |
|
2023 |
Pascual-Reguant L, Serra-Camprubí Q, Datta D, Cianferoni D, Kourtis S, Gañez-Zapater A, Cannatá C, Espinar L, Querol J, García-López L, Musa-Afaneh S, Guirola M, Gkanogiannis A, Miró Canturri A, Guzman M, et al. Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer. Embo Molecular Medicine. e18459. PMID 37937685 DOI: 10.15252/emmm.202318459 |
0.28 |
|
2022 |
Serra V, Wang AT, Castroviejo-Bermejo M, Polanska UM, Palafox M, Herencia-Ropero A, Jones GN, Lai Z, Armenia J, Michopoulos F, Llop-Guevara A, Brough R, Gulati A, Pettitt SJ, Bulusu KC, ... ... Rodriguez O, et al. Identification of a molecularly-defined subset of breast and ovarian cancer models that respond to WEE1 or ATR inhibition, overcoming PARP inhibitor resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35921524 DOI: 10.1158/1078-0432.CCR-22-0568 |
0.278 |
|
2011 |
Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. The European Journal of Neuroscience. 33: 1598-610. PMID 21453448 DOI: 10.1111/J.1460-9568.2011.07660.X |
0.272 |
|
2013 |
Pablico-Lansigan MH, Hickling WJ, Japp EA, Rodriguez OC, Ghosh A, Albanese C, Nishida M, Van Keuren E, Fricke S, Dollahon N, Stoll SL. Magnetic nanobeads as potential contrast agents for magnetic resonance imaging. Acs Nano. 7: 9040-8. PMID 24047405 DOI: 10.1021/Nn403647T |
0.271 |
|
2022 |
Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, et al. High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER breast cancer. Nature Communications. 13: 5258. PMID 36071033 DOI: 10.1038/s41467-022-32828-6 |
0.271 |
|
2015 |
Rodriguez O, Schaefer ML, Wester B, Lee YC, Boggs N, Conner HA, Merkle AC, Fricke ST, Albanese C, Koliatsos V. Manganese-Enhanced MRI as a diagnostic and dispositional tool after mild-moderate blast TBI. Journal of Neurotrauma. PMID 26414591 DOI: 10.1089/Neu.2015.4002 |
0.264 |
|
2015 |
Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein DI, Sidhu A. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death and Differentiation. 22: 838-51. PMID 25394490 DOI: 10.1038/Cdd.2014.179 |
0.25 |
|
2023 |
Naeem A, Knoer G, Laura Avantaggiati M, Rodriguez O, Albanese C. Provocative non-canonical roles of p53 and AKT signaling: A role for Thymosin β4 in medulloblastoma. International Immunopharmacology. 116: 109785. PMID 36720193 DOI: 10.1016/j.intimp.2023.109785 |
0.25 |
|
2021 |
Naeem A, Harish V, Coste S, Parasido EM, Choudhry MU, Kromer LF, Ihemelandu C, Petricoin EF, Pierobon M, Noon MS, Yenugonda VM, Avantaggiati M, Kupfer G, Fricke S, Rodriguez O, et al. Regulation of chemosensitivity in human medulloblastoma cells by p53 and the PI3 Kinase signaling pathway. Molecular Cancer Research : McR. PMID 34635507 DOI: 10.1158/1541-7786.MCR-21-0277 |
0.244 |
|
2017 |
Lee Y, Rodriguez OC, Albanese C, Santos VR, de Oliveira JAC, Donatti ALF, Fernandes A, Garcia-Cairasco N, N'Gouemo P, Forcelli PA. Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiology of Disease. PMID 29274430 DOI: 10.1016/J.Nbd.2017.12.014 |
0.234 |
|
2018 |
Main BS, Villapol S, Sloley SS, Barton DJ, Parsadanian M, Agbaegbu C, Stefos K, McCann MS, Washington PM, Rodriguez OC, Burns MP. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Molecular Neurodegeneration. 13: 17. PMID 29618365 DOI: 10.1186/S13024-018-0249-5 |
0.229 |
|
2022 |
Pellegrino B, Herencia-Ropero A, Llop-Guevara A, Pedretti F, Moles-Fernández A, Viaplana C, Villacampa G, Guzmán M, Rodríguez O, Grueso J, Jiménez J, Arenas EJ, Degasperi A, Dias JML, Forment JV, et al. Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. Cancer Research. 82: 1646-1657. PMID 35425960 DOI: 10.1158/0008-5472.CAN-21-2409 |
0.228 |
|
2019 |
Dahanayake V, Pornrungroj C, Pablico-Lansigan M, Hickling WJ, Lyons T, Lah D, Lee YC, Parasido E, Bertke JA, Albanese C, Rodriguez O, Van Keuren E, Stoll SL. Paramagnetic Clusters of Mn3(O2CCH3)6(Bpy)2 in Polyacrylamide Nanobeads as a New Design Approach to T1-T2 Multi-Modal MRI Contrast Agent. Acs Applied Materials & Interfaces. PMID 30964631 DOI: 10.1021/Acsami.9B03216 |
0.226 |
|
2019 |
Demby TC, Lee Y, Rodriguez O, Albanese C, Mandelblatt J, Rebeck GW. Abstract 667: A mouse model of APOE to define effects of doxorubicin on cognition Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-667 |
0.225 |
|
2021 |
Gris-Oliver A, Ibrahim YH, Rivas MA, García-García C, Sánchez-Guixé M, Ruiz-Pace F, Viaplana C, Pérez-García JM, Llombart-Cussac A, Grueso J, Parés M, Guzmán M, Rodríguez O, Anton P, Cozar P, et al. PI3K activation promotes resistance to eribulin in HER2-negative breast cancer. British Journal of Cancer. PMID 33723394 DOI: 10.1038/s41416-021-01293-1 |
0.22 |
|
2022 |
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, et al. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma. Nature Communications. 13: 2323. PMID 35484119 DOI: 10.1038/s41467-022-29898-x |
0.217 |
|
2021 |
Sánchez-Guixé M, Hierro C, Jiménez J, Viaplana C, Villacampa G, Monelli E, Brasó-Maristany F, Ogbah Z, Parés M, Guzmán M, Grueso J, Rodríguez O, Oliveira M, Azaro A, Garralda E, et al. High mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 28: 137-149. PMID 34593528 DOI: 10.1158/1078-0432.CCR-21-1810 |
0.212 |
|
2007 |
Peacock JG, Miller AL, Bradley WD, Rodriguez OC, Webb DJ, Koleske AJ. The Abl-related gene tyrosine kinase acts through p190RhoGAP to inhibit actomyosin contractility and regulate focal adhesion dynamics upon adhesion to fibronectin. Molecular Biology of the Cell. 18: 3860-72. PMID 17652459 DOI: 10.1091/Mbc.E07-01-0075 |
0.205 |
|
2022 |
Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, et al. Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER breast cancer. Nature Communications. 13: 6928. PMID 36376284 DOI: 10.1038/s41467-022-34580-3 |
0.205 |
|
2002 |
Rodriguez OC, Cheney RE. Human myosin-Vc is a novel class V myosin expressed in epithelial cells. Journal of Cell Science. 115: 991-1004. PMID 11870218 |
0.182 |
|
2019 |
Demby T, William Rebeck G, Albanese C, Rodriguez OC, Lee Y, Mandelblatt J. 3367 A Mouse Model of APOE Genotype in Chemotherapy Related Cognitive Impairment Journal of Clinical and Translational Science. 3: 1-1. DOI: 10.1017/cts.2019.6 |
0.179 |
|
2022 |
Liggett JR, Kang J, Ranjit S, Rodriguez O, Loh K, Patil D, Cui Y, Duttargi A, Nguyen S, He B, Lee Y, Oza K, Frank BS, Kwon D, Li HH, et al. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers. Frontiers in Immunology. 13: 898799. PMID 36148239 DOI: 10.3389/fimmu.2022.898799 |
0.177 |
|
2024 |
Shepard BD, Chau J, Kurtz R, Rosenberg AZ, Sarder P, Border SP, Ginley B, Rodriguez O, Albanese C, Knoer G, Greene A, De Souza AMA, Ranjit S, Levi M, Ecelbarger CM. Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice. American Journal of Physiology. Cell Physiology. 326: C1272-C1290. PMID 38602847 DOI: 10.1152/ajpcell.00446.2023 |
0.153 |
|
2023 |
Rosko LM, Gentile T, Smith VN, Manavi Z, Melchor GS, Hu J, Shults NV, Albanese C, Lee Y, Rodriguez O, Huang JK. Cerebral creatine deficiency affects the timing of oligodendrocyte myelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36732069 DOI: 10.1523/JNEUROSCI.2120-21.2022 |
0.127 |
|
2003 |
Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM, Waterman-Storer CM. Conserved microtubule-actin interactions in cell movement and morphogenesis. Nature Cell Biology. 5: 599-609. PMID 12833063 DOI: 10.1038/Ncb0703-599 |
0.126 |
|
2022 |
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, et al. Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma. Nature Communications. 13: 2729. PMID 35550518 DOI: 10.1038/s41467-022-30473-7 |
0.111 |
|
2013 |
Suman S, Rodriguez OC, Winters TA, Fornace AJ, Albanese C, Datta K. Therapeutic and space radiation exposure of mouse brain causes impaired DNA repair response and premature senescence by chronic oxidant production. Aging. 5: 607-22. PMID 23928451 |
0.107 |
|
2020 |
Prasad S, Chandra A, Cavo M, Parasido E, Fricke S, Lee Y, D'Amone E, Gigli G, Albanese C, Rodriguez O, Del Mercato LL. Optical and magnetic resonance imaging approaches for investigating the tumour microenvironment: state-of-the-art review and future trends. Nanotechnology. PMID 33065554 DOI: 10.1088/1361-6528/abc208 |
0.103 |
|
2022 |
Kurtz R, Libby A, Jones BA, Myakala K, Wang X, Lee Y, Knoer G, Lo Cascio JN, McCormack M, Nguyen G, Choos END, Rodriguez O, Rosenberg AZ, Ranjit S, Albanese C, et al. Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice. International Journal of Molecular Sciences. 23. PMID 35628485 DOI: 10.3390/ijms23105675 |
0.1 |
|
2008 |
Llano OG, Perez JC, Rodriguez OC, Guerra CM, Aguirre HG, Garza JL, Rodriguez-Romo L, Almaguer DG. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico. Pediatric Hematology and Oncology. 25: 39-47. PMID 18231953 DOI: 10.1080/08880010701773621 |
0.087 |
|
2021 |
Dahanayake V, Lyons T, Kerwin B, Rodriguez O, Albanese C, Parasido E, Lee Y, Keuren EV, Li L, Maxey E, Paunesku T, Woloschak G, Stoll SL. Paramagnetic MnFe--Polystyrene Nanobeads as a Potential T-T Multimodal Magnetic Resonance Imaging Contrast Agent with Studies. Acs Applied Materials & Interfaces. PMID 34375073 DOI: 10.1021/acsami.1c09232 |
0.082 |
|
2018 |
De la Calle C, Rodríguez O, Morata L, Marco F, Cardozo C, García-Vidal C, Del Río A, Feher C, Pellicé M, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA. CLINICAL CHARACTERISTICS AND PROGNOSIS OF INFECTIONS CAUSED BY OXA-48 CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN PATIENTS TREATED WITH CEFTAZIDIME-AVIBACTAM. International Journal of Antimicrobial Agents. PMID 30471403 DOI: 10.1016/j.ijantimicag.2018.11.015 |
0.081 |
|
2022 |
Jafari S, Baum IS, Udalov OG, Lee Y, Rodriguez O, Fricke ST, Jafari M, Amini M, Probst R, Tang X, Chen C, Ariando DJ, Hevaganinge A, Mair LO, Albanese C, et al. Opening the Blood Brain Barrier with an Electropermanent Magnet System. Pharmaceutics. 14. PMID 35890398 DOI: 10.3390/pharmaceutics14071503 |
0.078 |
|
2004 |
Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology. 55: 164-73. PMID 14755719 DOI: 10.1002/Ana.10795 |
0.069 |
|
2012 |
Wang SS, Rodriguez OC, Tian Y, Ye S, Petricoin E, Albanese C. Integration of imaging and systems biology to study treatment of medulloblastoma Proceedings - Ieee International Workshop On Genomic Signal Processing and Statistics. 22-25. DOI: 10.1109/GENSIPS.2012.6507717 |
0.059 |
|
2000 |
Rodriguez OC, Cheney RE. A new direction for myosin Trends in Cell Biology. 10: 307-311. PMID 10884682 DOI: 10.1016/S0962-8924(00)01797-9 |
0.058 |
|
2020 |
Mossali E, Picone N, Gentilini L, Rodrìguez O, Pérez JM, Colledani M. Lithium-ion batteries towards circular economy: A literature review of opportunities and issues of recycling treatments. Journal of Environmental Management. 264: 110500. PMID 32250918 DOI: 10.1016/j.jenvman.2020.110500 |
0.055 |
|
2021 |
Gremmels H, Winkel BMF, Schuurman R, Rosingh A, Rigter NAM, Rodriguez O, Ubijaan J, Wensing AMJ, Bonten MJM, Hofstra LM. Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. Eclinicalmedicine. 31: 100677. PMID 33521610 DOI: 10.1016/j.eclinm.2020.100677 |
0.053 |
|
2002 |
Stuart AE, Gebhardt KA, Vogel SN, Rodriguez O. Does the neurotransmitter transporter underlie adaptation at a histaminergic photoreceptor synapse? Visual Neuroscience. 19: 307-19. PMID 12392180 DOI: 10.1017/S0952523802193084 |
0.05 |
|
2015 |
López FA, Alguacil FJ, Rodríguez O, Sierra MJ, Millán R. Mercury leaching from hazardous industrial wastes stabilized by sulfur polymer encapsulation. Waste Management (New York, N.Y.). 35: 301-6. PMID 25458763 DOI: 10.1016/j.wasman.2014.10.009 |
0.047 |
|
2006 |
Rodriguez OC. Enthusiasm on the front lines: "the best job I ever had!". Interview by Barbara Zeiger. Ostomy/Wound Management. 52: 36-8. PMID 16700127 |
0.046 |
|
2000 |
Jesus SM, Porter MB, Stephan Y, Coelho E, Rodriguez OC, Demoulin X. Single sensor source localization in a range-dependent environment Oceans Conference Record (Ieee). 2: 865-868. |
0.045 |
|
2022 |
Lyons T, Kekedjian C, Glaser P, Ohlin CA, van Eldik R, Rodriguez O, Albanese C, Van Keuren E, Stoll SL. Molecular Parameters Promoting High Relaxivity in Cluster-Nanocarrier Magnetic Resonance Imaging Contrast Agents. Acs Applied Materials & Interfaces. PMID 36283049 DOI: 10.1021/acsami.2c12584 |
0.045 |
|
2012 |
Weinberg IN, Urdaneta MG, Stepanov PY, Beylin D, Nacev A, Sarwar A, Shapiro B, Rodriguez OC, Albanese C, Probst R, Fricke ST. Non-invasive image-guided brain access with gradient propulsion of magnetic nanoparticles Ieee Nuclear Science Symposium Conference Record. 3732-3734. DOI: 10.1109/NSSMIC.2012.6551857 |
0.045 |
|
2020 |
Mair LO, Hale O, Jafari S, Chen C, Udalov O, Probst R, Baum I, Hevaganinge A, Yi Wang E, Rodriguez OC, Albanese C, Fricke ST, Weinberg IN. Magnetic Microdevices for MRI-Based Detection of SARS-CoV-2 Viruses. Ieee Open Journal of Engineering in Medicine and Biology. 1: 265-267. PMID 33748768 DOI: 10.1109/ojemb.2020.3026234 |
0.041 |
|
2014 |
York JN, Albanese C, Rodriguez O, Le YC, Ackun-Farmmer M, Van Keuren E. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging. Journal of Biomedical Nanotechnology. 10: 3392-6. PMID 26000397 DOI: 10.1166/jbn.2014.1870 |
0.039 |
|
2017 |
Neckel ND, Dai H, Rodriguez OC. Addition of forelimb training reduces gains from robotic gait training in a rat model of spinal cord injury. Ieee ... International Conference On Rehabilitation Robotics : [Proceedings]. 2017: 346-351. PMID 28813843 DOI: 10.1109/ICORR.2017.8009271 |
0.038 |
|
2021 |
Neckel ND, Dai H, Hanckel J, Lee Y, Albanese C, Rodriguez O. Skilled Reach Training Enhances Robotic Gait Training To Restore Overground Locomotion Following Spinal Cord Injury In Rats. Behavioural Brain Research. 113490. PMID 34358574 DOI: 10.1016/j.bbr.2021.113490 |
0.035 |
|
2014 |
Kim SG, Gitterman Y, Rodriguez OC. Estimating depth and explosive charge weight for an extremely shallow underwater explosion of the ROKS Cheonan sinking in the Yellow Sea Methods in Oceanography. 11: 29-38. DOI: 10.1016/j.mio.2015.01.002 |
0.033 |
|
2020 |
Rodríguez O, Alguacil FJ, Baquero EE, García-Díaz I, Fernández P, Sotillo B, López FA. Recovery of niobium and tantalum by solvent extraction from Sn-Ta-Nb mining tailings. Rsc Advances. 10: 21406-21412. PMID 35518734 DOI: 10.1039/d0ra03331f |
0.032 |
|
2000 |
Rodriguez OC, Jesus SM. Physical limitations of travel-time-based shallow water tomography Journal of the Acoustical Society of America. 108: 2816-2822. DOI: 10.1121/1.1322019 |
0.031 |
|
2011 |
deWaard I, Abajian S, Gallagher MS, Hogue R, Keskin N, Koutropoulos A, Rodriguez OC. Using mLearning and MOOCs to understand chaos, emergence, and complexity in education International Review of Research in Open and Distance Learning. 12: 94-115. |
0.029 |
|
2007 |
Rodríguez O, Jarabo JR, Fernández E, Gómez A. [Sudden death in a patient with a mediastinal mass]. Cirugia Espanola. 82: 50. PMID 17580034 DOI: 10.1016/s0009-739x(07)71663-9 |
0.027 |
|
2013 |
Jenkins D, Rodríguez O. Access and success with less: improving productivity in broad-access postsecondary institutions. The Future of Children / Center For the Future of Children, the David and Lucile Packard Foundation. 23: 187-209. PMID 25522651 |
0.021 |
|
2012 |
Rodríguez O, Padilla I, Tayibi H, López-Delgado A. Concerns on liquid mercury and mercury-containing wastes: a review of the treatment technologies for the safe storage. Journal of Environmental Management. 101: 197-205. PMID 22446074 DOI: 10.1016/j.jenvman.2012.02.013 |
0.019 |
|
2008 |
Fernández E, Calatayud J, Jarabo JR, Hernando F, Rodríguez O, Gómez AM, Soria A, Del Río F. Profitability of our lung retrieval program from non heart beating donors. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 35: 287-91; discussion 2. PMID 19084424 DOI: 10.1016/j.ejcts.2008.10.030 |
0.01 |
|
2001 |
Cheney RE, Rodriguez OC. A switch to release the motor Science. 293: 1263-1264. PMID 11509712 DOI: 10.1126/science.1064602 |
0.01 |
|
Hide low-probability matches. |